Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 11934960)

1.

Unwillingness of rheumatoid arthritis patients to risk adverse effects.

Fraenkel L, Bogardus S, Concato J, Felson D.

Rheumatology (Oxford). 2002 Mar;41(3):253-61.

2.

Risk communication in rheumatoid arthritis.

Fraenkel L, Bogardus S, Concato J, Felson D.

J Rheumatol. 2003 Mar;30(3):443-8.

PMID:
12610798
3.
4.

The risk of treatment. A study of rheumatoid arthritis patients' attitudes.

Ho M, Lavery B, Pullar T.

Br J Rheumatol. 1998 Apr;37(4):459-60.

5.

Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication.

Goodacre LJ, Goodacre JA.

Rheumatology (Oxford). 2004 May;43(5):583-6. Epub 2004 Feb 17.

6.

Willingness to accept risk in the treatment of rheumatic disease.

O'Brien BJ, Elswood J, Calin A.

J Epidemiol Community Health. 1990 Sep;44(3):249-52.

7.
8.

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis.

Suissa S, Ernst P, Hudson M, Bitton A, Kezouh A.

Am J Med. 2004 Jul 15;117(2):87-92.

PMID:
15234643
9.

Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.

Alivernini S, Mazzotta D, Zoli A, Ferraccioli G.

Drugs Aging. 2009;26(5):395-402. doi: 10.2165/00002512-200926050-00003.

PMID:
19552491
10.

Patient preferences for treatment of rheumatoid arthritis.

Fraenkel L, Bogardus ST, Concato J, Felson DT, Wittink DR.

Ann Rheum Dis. 2004 Nov;63(11):1372-8. Epub 2004 Mar 5.

11.
12.

Safety of extended treatment with anakinra in patients with rheumatoid arthritis.

Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B.

Ann Rheum Dis. 2006 Aug;65(8):1006-12. Epub 2006 Jan 5.

14.
15.

Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis.

Neame R, Hammond A.

Rheumatology (Oxford). 2005 Jun;44(6):762-7. Epub 2005 Mar 1.

16.

Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.

Díaz-Borjón A.

Drugs Aging. 2009;26(4):273-93. doi: 10.2165/00002512-200926040-00001. Review.

PMID:
19476397
17.
18.

Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.

Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW.

Clin Ther. 2006 Dec;28(12):2052-60.

PMID:
17296461
19.

[Pharmaceutical care of patients with rheumatoid and psoriatic arthritis receiving etanercept].

Romero Crespo I, Antón Torres R, Borrás Blasco J, Navarro Ruiz A.

Farm Hosp. 2005 May-Jun;29(3):171-6. Spanish.

20.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk